Cargando…

Effects of Vitamin D3 on Intestinal Flora in a Mouse Model of Inflammatory Bowel Disease Treated with Rifaximin

BACKGROUND: Rifaximin is an antimicrobial agent used to treat inflammatory bowel disease (IBD). Vitamin D3 can control IBD due to its effects on inflammatory cytokines. The purpose of this study was to assess the effect of vitamin D3 on the intestinal flora of a dextran sulfate sodium (DSS)-induced...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gu, Zijun, Duan, Mingxiu, Sun, Yan, Leng, Tian, Xu, Ting, Gu, Yang, Gu, Zejuan, Lin, Zheng, Yang, Lu, Ji, Minghui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	International Scientific Literature, Inc. 2020
Materias:	Animal Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670830/ https://www.ncbi.nlm.nih.gov/pubmed/33177483 http://dx.doi.org/10.12659/MSM.925068

Ejemplares similares

Rifaximin Improves Visceral Hyperalgesia via TRPV1 by Modulating Intestinal Flora in the Water Avoidance Stressed Rat
por: Yang, Chang-qing, et al.
Publicado: (2020)

Analysis of the Therapeutic Effect of Changyanning on Intestinal Flora in Inflammatory Bowel Disease
por: Hu, Xinyu, et al.
Publicado: (2022)

LACC1 regulates changes in the intestinal flora in a mouse model of inflammatory bowel disease
por: Xu, Zheng-Yuan, et al.
Publicado: (2023)

Rifaximin Therapy of Irritable Bowel Syndrome
por: Koo, Hoonmo L., et al.
Publicado: (2012)

Rifaximin for small intestinal bacterial overgrowth in patients without irritable bowel syndrome
por: Boltin, Doron, et al.
Publicado: (2014)

Intestinal Flora and Vitamin B(1)
Publicado: (1944)

Characterization of the intestinal mucosal proteome in cats with inflammatory bowel disease and alimentary small cell lymphoma
por: Marsilio, Sina, et al.
Publicado: (2021)

The role of complex interactions between the intestinal flora and host in regulating intestinal homeostasis and inflammatory bowel disease
por: Li, Siyu, et al.
Publicado: (2023)

New insights into the interplay between intestinal flora and bile acids in inflammatory bowel disease
por: Zheng, Lie
Publicado: (2022)

THE INTESTINAL FLORA IN MOUSE TYPHOID INFECTION
por: Webster, Leslie T.
Publicado: (1923)

Effects of Intestinal Flora on Irritable Bowel Syndrome and Therapeutic Significance of Polysaccharides
por: Ye, Yang, et al.
Publicado: (2022)

Profile of rifaximin and its potential in the treatment of irritable bowel syndrome
por: Iorio, Natalya, et al.
Publicado: (2015)

Narrative Review: Pathogenesis of the Inflammatory Response and Intestinal Flora in Depression
por: Zeng, Jia-Wei, et al.
Publicado: (2023)

The association between serum vitamin D and inflammatory bowel disease
por: Zhao, Jianmin, et al.
Publicado: (2019)

Campylobacter Species and Neutrophilic Inflammatory Bowel Disease in Cats
por: Maunder, C.L., et al.
Publicado: (2016)

Contrast‐enhanced ultrasonography in dogs with inflammatory bowel disease
por: Linta, Nikolina, et al.
Publicado: (2021)

Rifaximin Alters Intestinal Microbiota and Prevents Progression of Ankylosing Spondylitis in Mice
por: Yang, Lianjun, et al.
Publicado: (2019)

Abdominal Pain Response to Rifaximin in Patients With Irritable Bowel Syndrome With Diarrhea
por: Lembo, Anthony, et al.
Publicado: (2020)

Updated immunomodulatory roles of gut flora and microRNAs in inflammatory bowel diseases
por: Cheng, Ting, et al.
Publicado: (2022)

Rifaximin ameliorates intestinal inflammation in cirrhotic patients with hepatic encephalopathy
por: Tamai, Yasuyuki, et al.
Publicado: (2021)

Immunophenotype of Peripheral Blood Lymphocytes in Dogs with Inflammatory Bowel Disease
por: Galler, A., et al.
Publicado: (2017)

Plasma amino acid profiles in dogs with inflammatory bowel disease
por: Tamura, Yu, et al.
Publicado: (2019)

Novel MAGL Inhibitors Alleviate LPS-Induced Acute Kidney Injury by Inhibiting NLRP3 Inflammatory Vesicles, Modulating Intestinal Flora, Repairing the Intestinal Barrier, and Interfering with Serum Metabolism
por: Xiang, Haixin, et al.
Publicado: (2023)

Evaluation of novel serological markers and autoantibodies in dogs with inflammatory bowel disease
por: Estruch, Juan J., et al.
Publicado: (2020)

Characterization of intestinal fibrosis in cats with chronic inflammatory enteropathy
por: Bandara, Yuvani, et al.
Publicado: (2023)

Vitamin D Modulates Intestinal Microbiota in Inflammatory Bowel Diseases
por: Battistini, Carolina, et al.
Publicado: (2020)

High-dose rifaximin treatment alleviates global symptoms of irritable bowel syndrome
por: Jolley, John
Publicado: (2011)

Effect of Intestinal Microbiota Transplantation on Intestinal Flora and Inflammatory Factor Levels in Patients with Ulcerative Colitis
por: Wang, Zhi, et al.
Publicado: (2023)

Effect of Different Doses of Vitamin D on the Intestinal Flora of Babies with Eczema: An Experimental Study
por: Liu, Youping, et al.
Publicado: (2022)

Effects of Lactobacillus Lactis Supplementation on Growth Performance, Hematological Parameters, Meat Quality and Intestinal Flora in Growing-Finishing Pigs
por: Duan, Haitao, et al.
Publicado: (2023)

Herbal Therapy Is Equivalent to Rifaximin for the Treatment of Small Intestinal Bacterial Overgrowth
por: Chedid, Victor, et al.
Publicado: (2014)

Intestinal Flora: A Potential Mechanism by Which Yinlai Decoction Treats Lipopolysaccharide-Induced Pneumonia
por: Xu, Jingnan, et al.
Publicado: (2022)

Gene expression profiling of the mouse gut: Effect of intestinal flora on intestinal health
por: Zhu, Wenhua, et al.
Publicado: (2018)

The role of intestinal immune cells and matrix metalloproteinases in inflammatory bowel disease
por: Mei, Kun, et al.
Publicado: (2023)

PB2405: BAICALIN MODULATES INTESTINAL FLORA TO TREAT AGVHD
por: Yang, Jingrong, et al.
Publicado: (2023)

Intestinal Flora and Nutrition
por: Hughes, R.
Publicado: (1944)

Clinical signs, duodenal histopathological grades, and serum high‐mobility group box 1 concentrations in dogs with inflammatory bowel disease
por: Lee, Jong‐Hwan, et al.
Publicado: (2021)

Rifaximin for Irritable Bowel Syndrome: A Meta-Analysis of Randomized Placebo-Controlled Trials
por: Li, Jun, et al.
Publicado: (2016)

Serologic and fecal markers to predict response to induction therapy in dogs with idiopathic inflammatory bowel disease
por: Otoni, Cristiane C., et al.
Publicado: (2018)

Modulation of the microbiota across different intestinal segments by Rifaximin in PI-IBS mice
por: Zhang, Shengyan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_51lp1cb52503do8f7h6rvs522l